Tagrix 80 Mg ( OSIMERTINIB) | Buy Generic Osimertinib IEB PHARMA

Tagrix 80 mg, containing the active ingredient Osimertinib, is a groundbreaking medication used in the treatment of non-small cell lung cancer (NSCLC). Manufactured by IEB Pharma, Tagrix is specifically designed to target tumors with specific mutations in the epidermal growth factor receptor (EGFR) gene, notably the T790M mutation, which is associated with resistance to other EGFR inhibitors.

As a third-generation EGFR tyrosine kinase inhibitor (TKI), Tagrix works by blocking the activity of EGFR proteins, thereby inhibiting tumor growth and progression. It is indicated for the treatment of metastatic NSCLC in patients whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as well as those who have developed resistance to prior EGFR TKI therapy due to the T790M mutation.